A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine

Table 1 Summary of demographic characteristics (ATP cohort for immunogenicity)

Characteristics	parameters or categories	A		B		C		D		E		F		Total
		N = 92		N = 86		N = 92		N = 89		N = 91		N = 91		N = 541
		Value or n	%	Value or n	%	Value or n	%	Value or n	%	Value or n	%	Value or n	%	Value or n	%
Age (years)	Mean	29.6	-	28.8	-	28.0	-	29.3	-	29.6	-	28.5	-	29.0	-
	SD	6.30	-	6.46	-	6.41	-	6.21	-	6.45	-	6.19	-	6.34	-
	Median	29.5	-	28.0	-	27.0	-	29.0	-	29.0	-	27.0	-	28.0	-
	Minimum	19	-	19	-	19	-	19	-	19	-	19	-	19	-
	Maximum	40	-	40	-	40	-	40	-	40	-	40	-	40	-
Gender	Female	47	51.1	49	57.0	50	54.3	43	48.3	57	62.6	55	60.4	301	55.6
Gender	Male	45	48.9	37	43.0	42	45.7	46	51.7	34	37.4	36	39.6	240	44.4
Ethnicity	American hispanic or latino	11	12.0	9	10.5	7	7.6	5	5.6	4	4.4	11	12.1	47	8.7
Ethnicity	Not american hispanic or latino	81	88.0	77	89.5	85	92.4	84	94.4	87	95.6	80	87.9	494	91.3
Geographic Ancestry	African heritage/african american	14	15.2	11	12.8	14	15.2	13	14.6	11	12.1	15	16.5	78	14.4
	American indian or alaskan native	1	1.1	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	1	0.2
	Asian - central/south asian heritage	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	1	1.1	1	0.2
	Asian - east asian heritage	0	0.0	1	1.2	1	1.1	1	1.1	0	0.0	1	1.1	4	0.7
	Asian - japanese heritage	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0
	Asian - south east asian heritage	0	0.0	1	1.2	0	0.0	0	0.0	0	0.0	2	2.2	3	0.6
	Native hawaiian or other pacific islander	0	0.0	0	0.0	3	3.3	0	0.0	0	0.0	0	0.0	3	0.6
	White - arabic/north african heritage	1	1.1	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	1	0.2
	White - caucasian/european heritage	74	80.4	72	83.7	73	79.3	75	84.3	78	85.7	70	76.9	442	81.7
	Other	2	2.2	1	1.2	1	1.1	0	0.0	2	2.2	2	2.2	8	1.5

ISSN: 1471-2334